Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors. - Wikidata - awgldk - TriplyDB

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

http://www.wikidata.org/entity/Q34303603

about

Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International Sites Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor.Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa.Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China Factors influencing the efficacy of rilpivirine in HIV-1 subtype C in low- and middle-income countries.A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.Patterns of HIV-1 Drug-Resistance Mutations among Patients Failing First-Line Antiretroviral Treatment in South India.Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.The global burden of HIV-1 drug resistance in the past 20 years.

P2860

Q28550335-96FBC8FB-CBBA-49E4-84E5-40331E409B96 Q30000270-CBBD3A7D-4F8A-4FE9-87BF-F0E55A796FFF Q35607740-E72F06C8-9E94-4832-BE8A-5564B8D9093E Q36109276-6CA2CD2C-8BD9-4646-8EE7-D88DC0125094 Q36252846-AFAC8264-27D5-4CB9-BA7A-31578BE3A011 Q36455357-0155AFC5-9D6D-432C-8719-4803CFE5A162 Q38748311-6DE928A2-DFA9-4484-9C79-A0F6C68B8DFE Q38962278-80DE8877-30E8-43FF-88F0-CC70731A8F1C Q47218587-CD297C61-C9B9-49BC-A8AA-A1068DF123EE Q55262913-6DB8BEAB-23BD-4EB5-8E5E-A8BA266E887B

P2860

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

http://www.wikidata.org/entity/Q34303603

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@ast

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@en

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@nl

type

label

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@ast

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@en

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@nl

prefLabel

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@ast

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@en

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@nl

P1433

Q34303603-5BBCF924-00FA-41A5-AD63-16966EF726B4

P1476

Q34303603-CB806F0D-D55A-4F3D-B4CE-3A550A652284

P2093

Q34303603-057B9BBA-75EA-40B8-B057-8C82A537AE9D

Q34303603-451A6C40-580C-42F8-83A1-0B5503982082

Q34303603-4C2680C8-7D5F-4F59-BD18-1D852545976D

Q34303603-60395E02-26F0-4A93-989F-55276C97859B

Q34303603-7B7BA2F1-EFA7-441D-BE29-EB67066A63D6

Q34303603-DFD75804-4CA3-4F4B-910A-C01EBBFBFBCD

P275

Q34303603-3E41FDB2-4F56-48FB-90C0-068495851197

P2860

Q34303603-00718440-B08A-4390-853F-9BFDF0E6DEED

Q34303603-01E32C4D-91FA-472A-87F1-1449808D2A81

Q34303603-02677BA9-9596-49A6-B63A-5FDBEF95D5D7

Q34303603-0324E3E2-207A-4898-8275-444805672099

Q34303603-04CB8F3A-61F5-4EB8-A53D-F09740B0A368

Q34303603-04DA401E-98E4-43F6-BB1C-600AF2269BAD

Q34303603-09AF8AF3-C52C-4DC2-B527-3D28E3DB8F80

Q34303603-0E041D51-0021-4E7F-8FBA-1BD818E1369B

Q34303603-115484AC-679C-48AB-9B87-1AE201F2F793

Q34303603-118B3E17-DB94-4B97-A6DE-E0E73D41FD74

P304

Q34303603-C6B50E64-B3EB-45B5-9E3D-C447B0375CD3

P31

Q34303603-835D17E1-8832-49E1-84CD-BE77ADFBC8CF

Q34303603-E2B45239-2F6C-47DD-932E-CC3F5FFAF949

P356

Q34303603-9B692576-1A24-473F-ACBF-80CD36F5112E

P433

Q34303603-AFF24AAC-26E2-43DB-B6C4-05214487A3F0

P478

Q34303603-F3133EEB-E428-4159-A4D3-64DEFD5C1E77

P50

Q34303603-2B10A571-2E44-44B2-A5AA-DAD5CDB75659

Q34303603-53444027-785D-4D1B-811B-F4BA2E3F8EEC

Q34303603-CBDB868D-BB19-42D5-BCD8-C2798668A26E

Q34303603-E559A19F-75C4-4E22-84E0-5ED8E06D863C

Q34303603-E95FFD4E-685D-4C42-A2BB-6ABE420EAA22

P5008

Q34303603-7D8EA5FC-8ADA-485C-A9FB-641383D3272F

P577

Q34303603-E601E74F-D0DC-4931-820D-A702D6990096

P5875

Q34303603-9501E989-E014-4CDD-9E88-A947E06A01E4

P698

Q34303603-6962C0A8-A8D0-4756-B710-FE90E2F7440C

P921

Q34303603-18CBF0F2-DE48-454D-B094-C1A53AE8D30A

Q34303603-3E92DCA5-858E-4C1F-8BBA-1E6FC45AEDED

Q34303603-CFB244EC-D4CC-49C4-878E-C532568B4406

Q34303603-F5760773-5943-47EC-9594-BBDBEBCF8F01

P932

Q34303603-6BB48D4C-11C7-443D-AD8C-5C5E9C294B9E

P356

P1433

P1476

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

@en

P2093

Anders Sonnerborg

http://www.w3.org/2001/XMLSchema#string

Atsuko Hachiya

http://www.w3.org/2001/XMLSchema#string

Eddy Arnold

http://www.w3.org/2001/XMLSchema#string

Jacqueline A Flores

http://www.w3.org/2001/XMLSchema#string

Kamalendra Singh

http://www.w3.org/2001/XMLSchema#string

Michael Parniak

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

A new human immunodeficiency virus derived from gorillas

Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase

Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors

Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA.

P304

3535-3562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/V6093535

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Stefan G. Sarafianos

Carole P. McArthur

P5008

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266153364

http://www.w3.org/2001/XMLSchema#string

P698

25254383

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

physiological phenomena

P932

4189038

http://www.w3.org/2001/XMLSchema#string